Log in
Enquire now

List of Imago BioSciences Inc patents

List of Imago BioSciences Inc patents
List of Loxo Oncology patents
List of Bicycle Therapeutics patents
List of Obsidian Therapeutics patents
List of AI sustainability companies
List of companies in MITON's investment portfolio
Patents where
Current Assignee
Name
is
Imago BioSciences IncImago BioSciences Inc
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10882835 KDM1A inhibitors for the treatment of disease

Patent 10882835 was granted and assigned to Imago BioSciences Inc on January, 2021 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
10882835
January 5, 2021
‌
US Patent 10370346 KDM1A inhibitors for the treatment of disease

Patent 10370346 was granted and assigned to Imago BioSciences Inc on August, 2019 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
10370346
August 6, 2019
‌
US Patent 11230534 KDM1A inhibitors for the treatment of disease

Patent 11230534 was granted and assigned to Imago BioSciences Inc on January, 2022 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11230534
January 25, 2022
‌
US Patent 9981922 KDM1A inhibitors for the treatment of disease

Patent 9981922 was granted and assigned to Imago BioSciences Inc on May, 2018 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
9981922
May 29, 2018
‌
US Patent 9790195 KDM1A inhibitors for the treatment of disease

Patent 9790195 was granted and assigned to Imago BioSciences Inc on October, 2017 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
9790195
October 17, 2017
‌
US Patent 10519118 KDM1A inhibitors for the treatment of disease

Patent 10519118 was granted and assigned to Imago BioSciences Inc on December, 2019 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
10519118
December 31, 2019
‌
US Patent 11578059 KDM1A inhibitors for the treatment of disease

Patent 11578059 was granted and assigned to Imago BioSciences Inc on February, 2023 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11578059
February 14, 2023
‌
US Patent 11390590 Methods and processes for the preparation of KDM1A inhibitors

Patent 11390590 was granted and assigned to Imago BioSciences Inc on July, 2022 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11390590
July 19, 2022
‌
US Patent 11773068 KDM1A inhibitors for the treatment of disease

Patent 11773068 was granted and assigned to Imago BioSciences Inc on October, 2023 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11773068
October 3, 2023
‌
US Patent 11932629 KDM1A inhibitors for the treatment of disease

Patent 11932629 was granted and assigned to Imago BioSciences Inc on March, 2024 by the United States Patent and Trademark Office.

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11932629
March 19, 2024
‌
US Patent 11655226 KDM1A inhibitors for the treatment of disease

Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
Imago BioSciences Inc
United States Patent and Trademark Office
United States Patent and Trademark Office
11655226
May 23, 2023
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us